Blar i Department of Clinical Medicine på emneord "Treatment"
Viser treff 1-5 av 5
-
Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
(Peer reviewed; Journal article, 2019-08-12)Objective: Sporadic fatal adverse events have been reported during treatment of multiple sclerosis with alemtuzumab. To provide a systematic overview, we searched the centralized European Medicines Agency database of ... -
Disease-modifying treatments for multiple sclerosis – a review of approved medications
(Peer reviewed; Journal article, 2015-11-13)Background and purpose: There is still no curative treatment for multiple sclerosis (MS), but during the last 20 years eight different disease-modifying compounds have been approved for relapsing remitting MS (RRMS). ... -
Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report
(Peer reviewed; Journal article, 2015-04-30)Background: Erdheim-Chester disease is a rare histiocytosis characterized by multi-systemic organ involvement. Immune-modulating agents such as interferon-alpha have limited success and the disorder is progressive and ... -
Gastric diverticulum and halitosis - A case for surgery?
(Peer reviewed; Journal article, 2014-05-09)INTRODUCTION Gastric diverticulum is a rare and frequently asymptomatic condition. Symptoms include vague pain, fullness, dyspepsia, vomiting, hemorrhage and perforation. Occasionally, the patient can present with belching ... -
Severe traumatic brain injury in Norway: Impact of age on outcome
(Peer reviewed; Journal article, 2013-04-23)Objective: The aim of this study was to investigate the influence of age on mortality and 3-month outcome in a Norwegian cohort of patients with severe traumatic brain injury (TBI). Methods: Norwegian residents ≥ 16 years ...